课题基金 / 基金详情

IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)

IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)
预防结核分枝杆菌中心 (IMPAC-TB) 的免疫机制
批准号:
10027056
负责人:
RHEA COLER
金额:
$574.41万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-30 至 2021-09-29

项目摘要

项目成果

RHEA COLER的其他基金

相似基金

相关文献

中文摘要
翻译
该计划的目标是建立一个由高度协作的研究人员组成的综合多学科团队,对小动物、非人类灵长类动物(NHP)和人类的组织特异性和系统反应进行迭代、深入的免疫分析,以确定预防结核分枝杆菌所需的关键免疫反应;确定可用于改进结核病疫苗策略的免疫靶标。该计划下的其他研究活动可能包括确定 HIV/SIV 和非结核分枝杆菌 (NTM) 感染对 Mtb 感染或结核疫苗相关免疫反应的影响,以及确定细菌免疫逃避机制如何破坏对 Mtb 的免疫反应。
英文摘要
The goal of this program is to establish an integrated multi-disciplinary team of highly collaborative investigators that will plan and conduct iterative, in-depth immunologic analyses of tissue-specific and systemic responses in small animals, non-human primates (NHPs), and humans to identify the key immune responses needed for protection against Mtb; identify immunologic targets that can be used to improve TB vaccine strategies. Other research activities under the program may include determining the impact of HIV/SIV and Nontuberculous Mycobacteria (NTM) infection(s) on relevant immune responses to Mtb infection or TB vaccines and identifying how bacterial immune evasion mechanisms subvert immune responses to Mtb.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)
  • 批准号:
    10684963
  • 项目类别:
  • 资助金额:
    $578.13万
  • 财政年份:
    2021
  • 负责人:
    RHEA COLER
  • 依托单位:
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)
  • 批准号:
    10895252
  • 项目类别:
  • 资助金额:
    $1295.51万
  • 财政年份:
    2021
  • 负责人:
    RHEA COLER
  • 依托单位:
COMBINING PARASITE AND VECTOR COMPONENTS FOR DEVELOPMENT OF A LEISHMANIA VACCINE
  • 批准号:
    9357339
  • 项目类别:
  • 资助金额:
    $44.44万
  • 财政年份:
    2016
  • 负责人:
    RHEA COLER
  • 依托单位:
Adjuvant Development Program
海外基金